CompletedNot applicableNCT02621528

Lifetech CeraFlex™ Post-Market Surveillance Study

Studying Arterial duct anomaly

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Lifetech Scientific (Shenzhen) Co., Ltd.
Principal Investigator
Kevin Walsh, Professor
Our Lady's Children's Hospital, Crumlin
Intervention
CeraFlex(device)
Enrollment
120 enrolled
Eligibility
All sexes
Timeline
20152020

Study locations (7)

Collaborators

Medtronic

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02621528 on ClinicalTrials.gov

Other trials for Arterial duct anomaly

Additional recruiting or active studies for the same condition.

See all trials for Arterial duct anomaly

← Back to all trials